Please login to the form below

Not currently logged in
Email:
Password:

Gino Santini joins board of directors at Horizon

Former Lilly senior VP to help growth of US biopharma

Former senior VP of corporate strategy and business development at Eli Lilly & Company Gino Santini has joined the board of directors of Horizon Pharma.

This adds to his current positions on the boards of Allena Pharmaceuticals and AMAG Pharmaceuticals since leaving Lilly in 2010.

"We are pleased to welcome Gino to our board of directors," said Timothy Walbert, chairman, president and CEO of Horizon Pharma.

"His extensive domestic and international commercial and business development experience and success will be an asset as Horizon continues to grow."

Gino Santini - Horizon Pharma
Gino Santini

Santini spent almost 30 years at Lilly, joining in 1983 as a financial planning associate in Italy.

He went to hold various positions in the company's financial and marketing divisions, before being appointed president of US operations in 1999; senior VP corporate strategy and policy in 2004; and senior VP corporate strategy and business development in 2008.

Outside Lilly, Santini has experience as chair of the board of the US National Pharmaceutical Council and of non-profit agency Noble, serving individuals with developmental disabilities.

He has also served on the board of directors for United Way and the executive committee and board of the Indianapolis Chamber of Commerce.

Meanwhile Horizon's current board member Louis Bock will not stand for re-election when his term expires at the 2012 annual meeting to be held on June 8, 2012 and Dr Hubert Birner has resigned from the company's Board.

"On behalf of the board of directors of Horizon Pharma, I would like to thank Lou and Hubert for their contributions, dedication and support of the company and its stockholders and we wish them both well," said Walbert.

13th March 2012

Share

Featured jobs

Subscribe to our email news alerts

PMHub

Add my company
Consulting at McCann Health

We are the strategic consultancy of McCann Health. We combine fresh and creative thinking with scientific and strategic depth...

Latest intelligence

segmentation_pie_thumb.jpg
If you’re not thinking segmentation, you’re not thinking
Having a background in market research I’ve been lucky to work on a number of customer segmentations in my time but working in creative communications it is still too rare...
Improving Outcomes in the Treatment of Opioid Dependence Highlights Report
The 16th annual ‘Improving Outcomes in the Treatment of Opioid Dependence’ (IOTOD)conference took place at the Hilton Madrid Airport hotel on 15–16 May 2018....
Londonvelophobia (fear of cycling in London) – debunked
...

Infographics